Our SARS-CoV-2 Multiplex Real Time RT-PCR Kit is a diagnostic test kit that targets 3 (two targets on the RdRp Gene and 1 target on the N Gene) different sequences in the RNA genome of SARS-CoV-2. If at least one RdRp target is positive, a positive diagnosis is the result. The kit has two different quantities either for 94 or 190 patients and has been validated on the following samples: 

  • Nasopharyngeal aspirate
  • Bronchoalveolar fluid
  • Sputum
  • Nasal Swab
sars-cov-2

Main features:

  • CE-IVD 
  • Follows the recommendationts of the WHO
  • Rapid results in less than 1h15m
  • Clinical sensitivity of 99% and a clinical specificity of 98.6%
  • Validated on the Applied Biosystems® 7500, the LightCycler®480 Instrument II and the CFX96TM Real Time PCR detection system
  • Validated in multiple hospitals in France and other European  countries

This test is based on real-time reverse-transcription and amplification which can be used for qualitative determination of the absence or presence of SARS-CoV-2 in RNA extract. The kit contains one oligomix to detect the three targets, as well as a control of RNA extraction and RT-PCR inhibition. That last control ensures that a negative result may be due to a bad RNA extraction. RNA of SARS-CoV-2 is detected with the use of specific probes for each target, labeled with FAM (target 1/RdRp gene), HEX (target 2/RdRp gene) and Texas Red (target 3/N gene). The RNA control (CI-ARN) is detected with a CY5 labeled probe. 

PCR tests that Goffin Molecular Technologies offers are European quality products produced in France. Our tests meet the highest standards in the market that are recommended by the WHO. 

We guarantee a stable supply. Goffin Molecular Technologies is able to deliver enough tests in the Netherlands every week as we got plenty in stock. 

If you want to receive more information about the kit like a brochure or a manual, you can send an email to info@goffinmt.com.

Download now

Send download to:

Share on facebook
Share on email
Share on linkedin

Copyright © 2020 Goffin Molecular Technologies